Rafaxone SB 500mg/250mg Injection
Marketer
Aarcin Pharmaceutical LLP
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Rafaxone SB 500mg/250mg Injection
Combiflox, a 500mg/250mg injectable dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and spread. Administration must be strictly under medical supervision; complete the prescribed course, even with symptom improvement, as premature cessation can compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia; escalating symptoms warrant immediate medical attention. Seek immediate help for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration promote faster recovery. Your doctor may order blood tests and imaging to monitor treatment response.
Uses of Rafaxone SB 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Rafaxone SB 500mg/250mg Injection:
This medication will be administered by your physician or registered nurse; please refrain from self-medicating.
Common Side effects of Rafaxone SB 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Rafaxone SB 500mg/250mg Injection:
Administering this medication will be handled by your healthcare provider; self-medication is strongly discouraged.
How Rafaxone SB 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Rafaxone SB 500mg/250mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam's role as a beta-lactamase inhibitor counters bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Rafaxone SB 500mg/250mg Injection use alongside alcohol consumption presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Rafaxone SB, 500mg/250mg, is typically deemed safe for use during gestation. Preclinical trials using animal models revealed minimal or no harmful consequences to the fetus; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
The administration of Rafaxone SB 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended until the maternal course of treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administration of Rafaxone SB 500mg/250mg Injection could reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Rafaxone SB 500mg/250mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Rafaxone SB (500mg/250mg) requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Patients should seek medical advice before using this medication. Dosage alterations for Rafaxone SB (500mg/250mg) injection are unnecessary for those with mild to moderate liver dysfunction.
What if you forget to take Rafaxone SB 500mg/250mg Injection :
Omitting a scheduled dose of Rafaxone SB 500mg/250mg Injection requires immediate physician consultation.
Facts to Know About Rafaxone SB 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently